Gary S. Jacob - SEC Form 4 Insider Trading Activity
CHIEF DEVELOPMENT OFFICER, Director
Summary
Updated Aug 16, 2026
Gary S. Jacob has filed 2 SEC Form 4 filings across 1 company in the last 90 days - buying. Lifetime open-market purchases: $5K.
Profile
Gary S. Jacob holds the role of CHIEF DEVELOPMENT OFFICER at OKYO Pharma Ltd (OKYO). Jacob has reported 1 insider filing with the SEC since 2026. The most recent filing was in July 2026.
- Role
- CHIEF DEVELOPMENT OFFICER, Director
Board memberships
- OKYO Pharma Ltd
Trading Pattern
InsiderAlpha's records for Gary S. Jacob go back to 2026: 2 primary Form 4 filings, an average of 2.0 per year. The typical open-market purchase is $5K (1 buy totaling $5K). The largest single buy on record is $5K of OKYO in 2026. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Career & Filing History
Every role Gary S. Jacob has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
- CHIEF DEVELOPMENT OFFICER, Director at OKYO Pharma Ltd (OKYO) - 2 filings, 2026
Recent Transactions
2Companies - Last 90 Days
1- OKYO Pharma Ltd (OKYO) - 2 filings, last 2026-08-07
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades at the companies Gary S. Jacob has recently filed at. Multiple unrelated insiders buying the same stock within a short window - cluster buying - has historically been one of the strongest Form 4 signals.
- Gabriele M. Cerrone - $35K of OKYO open-market activity in the last 12 months
- Flavio Mantelli - $28K of OKYO open-market activity in the last 12 months
- Robert John Dempsey - $23K of OKYO open-market activity in the last 12 months
- John P. Brancaccio - $7K of OKYO open-market activity in the last 12 months
- Rajkumar V. Patil - $5K of OKYO open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Gary S. Jacob?
Gary S. Jacob holds the role of CHIEF DEVELOPMENT OFFICER at OKYO Pharma Ltd (OKYO). Jacob has reported 1 insider filing with the SEC since 2026. The most recent filing was in July 2026.…
How many SEC Form 4 filings has Gary S. Jacob submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Gary S. Jacob been buying or selling stock?
Recorded transactions: 1 open-market purchase ($5K) and 0 open-market sales across all tracked filings.
Where can I see all of Gary S. Jacob's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Get alerts when Gary S. Jacob files a new Form 4
Track every insider buy in real time, with AI-scored daily trade ideas and 10b5-1 plan flags.
Free during early access · No credit card required